InfuSystems Holdings Inc. (INFU)
NYSE: INFUHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
INFU stock chart
Technical analysisKey statistics
All statistics- Market cap
- $287.48M
- P/E (TTM)
- 32.61
- Forward P/E
- 25.63
- EPS (TTM)
- $0.44
- Dividend yield
- None
- 52-week range
- 7.29 – 15.47
- Day range
- 13.77 – 14.44
- Volume / Avg
- 214.71K / 136.60K
- Beta
- —
- Shares outstanding
- 20.03M
52-week range
INFU stock today
Shares of InfuSystems (INFU) finished higher on Nov 20 at $14.35, a gain of 2.06% or $0.29 per share, versus the S&P 500's 3.70% decline. At this level, INFU sits near the top of its 52-week range of $7.29 to $15.47: 7.2% below the high, set on Nov 11, 2026 and 96.8% above the low. INFU is up 60.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 51.7%.
InfuSystems trades at 32.6x its trailing twelve-month earnings per share of $0.44. Its forward P/E of 25.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About InfuSystems
Company profileInfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Ms. Carrie A. Lachance B.S.N., M.B.A., R.N.
- Headquarters
- Rochester Hills, MI
- Employees
- 461
- Website
- infusystem.com
Financial highlights
Full financialsIn fiscal 2025, InfuSystems generated $143.4 million in revenue, up 6.4% from fiscal 2024, its 7th consecutive year of revenue growth. Net income was $6.6 million (+182.6% year over year), for a net margin of 4.6% versus a median of 1.4% in the prior 5 years. Gross margin was 56.0% (up from 52.2%) and operating margin 8.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $143.44M | $134.86M | $125.78M | $109.91M | $102.38M |
| Growth | +6.36% | +7.22% | +14.44% | +7.36% | +5.13% |
| Net income | $6.63M | $2.35M | $872.00K | $18.00K | $1.42M |
| EPS (diluted) | $0.31 | $0.11 | $0.04 | $0.00 | $0.06 |
Analyst forecast
ForecastConsensus (3 analysts)
strong_buy
Avg. price target
$18.50+28.92%
- Strong buy 0
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.15 vs —
INFU news
All INFU newsInfuSystems peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TMCITreace Medical Concepts Inc. | 4.31 | -0.92% | $282.56M | vs INFU |
| NPCENeuropace Inc. | 7.95 | -2.33% | $273.89M | vs INFU |
| SSIISS Innovations International Inc. | 1.27 | -0.78% | $254.86M | vs INFU |
| OFIXOrthofix Medical Inc. | 6.07 | -4.26% | $247.41M | vs INFU |
| OSUROraSure Technologies Inc. | 3.46 | -4.16% | $238.90M | vs INFU |
| PROFProfound Medical Corp. | 6.38 | -3.19% | $233.68M | vs INFU |
| EMBCEmbecta Corp. | 6.02 | -2.75% | $341.09M | vs INFU |
| BWAYBrainsWay Ltd. ADR | 8.48 | -2.86% | $341.35M | vs INFU |
Indexes, lists and sector
InfuSystems stock FAQ
What is InfuSystems's stock price today?
INFU last traded at $14.35 as of Nov 20, 4:00 PM EST, up 2.06% on the day. Prices are delayed at least 15 minutes.
What is INFU's P/E ratio?
INFU trades at a trailing P/E ratio of 32.61 and a forward P/E of 25.63.
Who is InfuSystems's CEO?
Ms. Carrie A. Lachance B.S.N., M.B.A., R.N. is the chief executive officer of InfuSystems Holdings Inc., which has about 461 employees.
What is the INFU 52-week high?
The 52-week high for INFU is $15.47 and the 52-week low is $7.29. The stock is currently 7.2% below its high.